This communication demonstrates an approach to generate simple nanostructures with critical dimensions down to 30 nm over cm2-sized areas using composite PDMS masks. These masks were patterned with feature sizes down to 100 nm. When used in phase-shifting lithography, these masks generated arrays of structures in photoresist with line widths as small as 30 nm, slots in metal with features down ...

Non-linear special relativity (or doubly special relativity) is a simple framework for encoding properties of flat quantum space-time. In this paper we show how this formalism may be generalized to incorporate curvature (leading to what might be called “doubly general relativity”). We first propose a dual to non-linear realizations of relativity in momentum space, and show that for such a dual ...

The availability of drugs that can cure hepatitis C virus infection provides a wonderful backdrop for the Journal of Hepatology to start its 31st year. It is clear to us all that the landscape of Hepatology will change within the next 10 years and therefore it is very exciting to introduce this supplement. Despite this progress, deaths from liver disease are occurring at a staggering rate (Tabl...

The binding energies and proton separation of nuclides with $Z, N = 30-50$ are investigated, based on the shell model an uncertainty analysis through statistical methods. Several formulas used to obtain according shell-model calculations. non-parametric Bootstrap method is applied establish decomposition recomposition framework. Moreover, it estimate stability proton(s) emission for each nuclid...

BACKGROUND Based on the increased consumption of alcohol in Denmark the aim of this study was to measure prevalence of abnormal liver-derived enzymes in a homogeneous Danish population and possible associations with alcohol consumption, smoking and body mass index (BMI). METHOD In a representative population sample of 905 people (aged 30-50) from the baseline survey of the Ebeltoft Health Pro...

Sodium glucose cotransporter 2 (SGLT2) inhibition is a novel and promising treatment for diabetes under late-stage clinical development. It generally is accepted that SGLT2 mediates 90% of renal glucose reabsorption. However, SGLT2 inhibitors in clinical development inhibit only 30-50% of the filtered glucose load. Why are they unable to inhibit 90% of glucose reabsorption in humans? We will tr...